|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with ADRA2 x cPLA2α x GR
100 Translational Medicine associated with ADRA2 x cPLA2α x GR
0 Patents (Medical) associated with ADRA2 x cPLA2α x GR